Literature DB >> 15315848

Protollin: a novel adjuvant for intranasal vaccines.

Taff Jones1, Sonya Cyr, Francine Allard, Nathalie Bellerose, George H Lowell, David S Burt.   

Abstract

Protollin is a novel adjuvant comprising Proteosomes non-covalently complexed with LPS. Intranasal immunization of mice with Protollin combined with detergent-split influenza antigens (HA) or recombinant influenza hemagglutinin (rHA) enhanced serum IgG and mucosal IgA levels by up to 250-fold compared with immunization with the antigens alone. IFN-gamma responses were also enhanced compared to the levels produced by splenocytes from mice immunized with antigen alone, while production of IL-5 was abrogated. Mice immunized with Protollin-rHA were completely protected against lethal challenge with influenza virus, demonstrating that Protollin is an effective mucosal adjuvant for prophylactic vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15315848     DOI: 10.1016/j.vaccine.2004.03.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis.

Authors:  J B Knight; Y Y Huang; S A Halperin; R Anderson; A Morris; A Macmillan; T Jones; D S Burt; G Van Nest; S F Lee
Journal:  Clin Exp Immunol       Date:  2006-06       Impact factor: 4.330

2.  Effects of different adjuvants in the context of intramuscular and intranasal routes on humoral and cellular immune responses induced by detergent-split A/H3N2 influenza vaccines in mice.

Authors:  Mariana Baz; Mukesh Samant; Hakima Zekki; Pascale Tribout-Jover; Martin Plante; Anne-Marie Lanteigne; Marie-Eve Hamelin; Corey Mallett; Barbara Papadopoulou; Guy Boivin
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

3.  Nasal vaccination with a proteosome-based adjuvant and glatiramer acetate clears beta-amyloid in a mouse model of Alzheimer disease.

Authors:  Dan Frenkel; Ruth Maron; David S Burt; Howard L Weiner
Journal:  J Clin Invest       Date:  2005-08-11       Impact factor: 14.808

4.  The EtpA exoprotein of enterotoxigenic Escherichia coli promotes intestinal colonization and is a protective antigen in an experimental model of murine infection.

Authors:  Koushik Roy; David Hamilton; Kenneth P Allen; Mildred P Randolph; James M Fleckenstein
Journal:  Infect Immun       Date:  2008-02-19       Impact factor: 3.441

5.  Cross-lineage influenza B and heterologous influenza A antibody responses in vaccinated mice: immunologic interactions and B/Yamagata dominance.

Authors:  Danuta M Skowronski; Marie-Eve Hamelin; Naveed Z Janjua; Gaston De Serres; Jennifer L Gardy; Chantal Rhéaume; Xavier Bouhy; Guy Boivin
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

6.  Directed evaluation of enterotoxigenic Escherichia coli autotransporter proteins as putative vaccine candidates.

Authors:  Jessica A Harris; Koushik Roy; Virginia Woo-Rasberry; David J Hamilton; Rita Kansal; Firdausi Qadri; James M Fleckenstein
Journal:  PLoS Negl Trop Dis       Date:  2011-12-06

Review 7.  Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.

Authors:  D Farfara; V Lifshitz; D Frenkel
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

Review 8.  Bacterial outer membrane vesicles and vaccine applications.

Authors:  Reinaldo Acevedo; Sonsire Fernández; Caridad Zayas; Armando Acosta; Maria Elena Sarmiento; Valerie A Ferro; Einar Rosenqvist; Concepcion Campa; Daniel Cardoso; Luis Garcia; Jose Luis Perez
Journal:  Front Immunol       Date:  2014-03-24       Impact factor: 7.561

9.  Immunopotentiation of Different Adjuvants on Humoral and Cellular Immune Responses Induced by HA1-2 Subunit Vaccines of H7N9 Influenza in Mice.

Authors:  Li Song; Dan Xiong; Maozhi Hu; Xilong Kang; Zhiming Pan; Xinan Jiao
Journal:  PLoS One       Date:  2016-03-01       Impact factor: 3.240

10.  Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.

Authors:  Qingwei Luo; Tim J Vickers; James M Fleckenstein
Journal:  Clin Vaccine Immunol       Date:  2016-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.